In silico studies for the rational discovery of anticonvulsant compounds.
暂无分享,去创建一个
[1] M. Wagner. Felbamate: a new antiepileptic drug. , 1994, American journal of hospital pharmacy.
[2] J. Stables,et al. Synthesis of 2-piperidinecarboxylic acid derivatives as potential anticonvulsants , 1998 .
[3] J. Stewart. Optimization of parameters for semiempirical methods I. Method , 1989 .
[4] E. Gordon,et al. Combinatorial chemistry and molecular diversity in drug discovery , 1998 .
[5] M. Brodie,et al. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy , 1995, The Lancet.
[6] Ernesto Estrada,et al. Spectral Moments of the Edge Adjacency Matrix in Molecular Graphs, 1. Definition and Applications to the Prediction of Physical Properties of Alkanes , 1996, J. Chem. Inf. Comput. Sci..
[7] Peter Welling. The Drug Development Process : Increasing Efficiency and Cost-Effectiveness , 1996 .
[8] E. Perucca,et al. The new generation of antiepileptic drugs: advantages and disadvantages. , 1996, British journal of clinical pharmacology.
[9] J. Stables,et al. Synthesis and anticonvulsant activities of N-Benzyl-2-acetamidopropionamide derivatives. , 1996, Journal of medicinal chemistry.
[10] S. Venkatesh,et al. Role of the development scientist in compound lead selection and optimization. , 2000, Journal of pharmaceutical sciences.
[11] N. Cosford,et al. Chapter 7 - Recent Progress In Antiepileptic Drug Research , 1998 .
[12] Alexandru T. Balaban,et al. From chemical topology to three-dimensional geometry , 2002 .
[13] J. Quail,et al. (Aryloxy)aryl semicarbazones and related compounds: a novel class of anticonvulsant agents possessing high activity in the maximal electroshock screen. , 1996, Journal of medicinal chemistry.
[14] Isa,et al. Synthesis and anticonvulsant activity of 2(3H)-benzoxazolone and 2(3H)-benzothiazolone derivatives , 1998, Journal of medicinal chemistry.
[15] Ernesto Estrada,et al. A novel approach for the virtual screening and rational design of anticancer compounds. , 2000, Journal of medicinal chemistry.
[16] K. Tipton,et al. Interactions of some analogues of the anticonvulsant milacemide with monoamine oxidase. , 1994, Biochemical pharmacology.
[17] Ernesto Estrada,et al. Edge Adjacency Relationships and a Novel Topological Index Related to Molecular Volume , 1995, J. Chem. Inf. Comput. Sci..
[18] F. Popp,et al. Potential anticonvulsants IV: Condensation of isatin with benzoylacetone and isopropyl methyl ketone. , 1982, Journal of pharmaceutical sciences.
[19] C. Rundfeldt,et al. D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures. , 1996, European journal of pharmacology.
[20] J. Poupaert,et al. Anticonvulsant activity and interactions with neuronal voltage-dependent sodium channel of analogues of ameltolide. , 1998, Journal of medicinal chemistry.
[21] J. Quail,et al. Anticonvulsant activity of various aryl, arylidene and aryloxyaryl semicarbazones , 1998 .
[22] L. Goodman,et al. The Pharmacological Basis of Therapeutics , 1941 .
[23] S. Mignani,et al. Riluzole series. Synthesis and in vivo "antiglutamate" activity of 6-substituted-2-benzothiazolamines and 3-substituted-2-imino-benzothiazolines. , 1999, Journal of medicinal chemistry.
[24] A. Crider,et al. Synthesis and anticonvulsant activity of racemic 2-amino-N-substituted succinimide derivatives. , 1981, Journal of pharmaceutical sciences.
[25] Ernesto Estrada,et al. Spectral Moments of the Edge-Adjacency Matrix of Molecular Graphs, 2. Molecules Containing Heteroatoms and QSAR Applications , 1997, J. Chem. Inf. Comput. Sci..
[26] P. Pevarello,et al. Synthesis and anticonvulsant activity of a new class of 2-[(arylalky)amino]alkanamide derivatives. , 1998, Journal of medicinal chemistry.
[27] E. Perucca,et al. Progress report on new antiepileptic drugs: a summary of the Third Eilat Conference , 1996, Epilepsy Research.
[28] P. Lehmann,et al. Partition coefficients of three new anticonvulsants. , 1990, Journal of pharmaceutical sciences.
[29] C. Elger,et al. New Antiepileptic Drugs in Epileptology , 1998, Neuropsychobiology.
[30] B. Cooper,et al. 1-(Fluorobenzyl)-4-amino-1H-1,2,3-triazolo[4,5-c]pyridines: synthesis and anticonvulsant activity. , 1995, Journal of medicinal chemistry.
[31] C. M. Darling,et al. Anticonvulsant activity of alkyl-substituted N-benzylcyanoacetamides. , 1979, Journal of pharmaceutical sciences.
[32] M. Bialer,et al. Structure-pharmacokinetic relationships in a series of short fatty acid amides that possess anticonvulsant activity. , 1990, Journal of pharmaceutical sciences.
[33] Ramón García-Domenech,et al. Designing sedative/hypnotic compounds from a novel substructural graph-theoretical approach , 1998, Journal of computer-aided molecular design.
[34] E. Lunney,et al. Transport of Gabapentin, a γ‐Amino Acid Drug, by System L α‐Amino Acid Transporters: A Comparative Study in Astrocytes, Synaptosomes, and CHO Cells , 1995 .
[35] J. Penry,et al. Antiepileptic Drug Development: I. History and a Program for Progress , 1978, Epilepsia.
[36] Ernesto Estrada,et al. Spectral Moments of the Edge Adjacency Matrix in Molecular Graphs. 3. Molecules Containing Cycles , 1998, J. Chem. Inf. Comput. Sci..
[37] W. Löscher,et al. Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? , 1994, Epilepsy Research.
[38] P. Patsalos. New Antiepileptic Drugs , 1999, Annals of clinical biochemistry.
[39] J. Korf,et al. Effect of milacemide, a glycinamide derivative, on the rat brain gamma-aminobutyric acid system. , 1983, Biochemical pharmacology.
[40] W. Löscher,et al. D-23129: a new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures , 1996, Epilepsy Research.
[41] J. Gobert,et al. ucb L059, a novel anti-convulsant drug: pharmacological profile in animals. , 1992, European journal of pharmacology.
[42] H. Lankau,et al. Synthesis, anticonvulsant activity, and structure-activity relationships of sodium channel blocking 3-aminopyrroles. , 1998, Journal of medicinal chemistry.
[43] F. Popp,et al. Potential anticonvulsants VI: condensation of isatins with cyclohexanone and other cyclic ketones. , 1983, Journal of pharmaceutical sciences.
[44] M A Rogawski,et al. Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. , 1990, Pharmacological reviews.
[45] B. Cooper,et al. 8-Amino-3-benzyl-1,2,4-triazolo[4,3-a]pyrazines. Synthesis and anticonvulsant activity. , 1995, Journal of medicinal chemistry.
[46] E Estrada,et al. Modeling chromatographic parameters by a novel graph theoretical sub-structural approach. , 1999, Journal of chromatography. A.
[47] M. Youdim,et al. Formation of the Neurotransmitter Glycine from the Anticonvulsant Milacemide Is Mediated by Brain Monoamine Oxidase B , 1988, Journal of neurochemistry.